Gene · 9531
Papers2,636
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,636
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Signaling plasticity in the integrated stress response. | Front Cell Dev Biol | 2023 | 38143923 | PubTator, text mining | PubMed |
| The Emerging Roles of the Metabolic Regulator G6PD in Human Cancers. | Int J Mol Sci | 2023 | 38139067 | PubTator, text mining | PubMed |
| Cardiac Magnetic Resonance as Risk Stratification Tool in Non-Ischemic Dilated Cardiomyopathy Referred for Implantable Cardioverter Defibrillator Therapy-State of Art and Perspectives. | J Clin Med | 2023 | 38137821 | PubTator, text mining | PubMed |
| Single-Cell Sequencing of Lung Macrophages and Monocytes Reveals Novel Therapeutic Targets in COPD. | Cells | 2023 | 38132091 | PubTator, text mining | PubMed |
| Novel pathogenic variant in MED12 causing non-syndromic dilated cardiomyopathy. | BMC Med Genomics | 2023 | 38129817 | PubTator, text mining | PubMed |
| Dysregulated Autophagy and Sarcomere Dysfunction in Patients With Heart Failure With Co-Occurrence of P63A and P380S BAG3 Variants. | J Am Heart Assoc | 2023 | 38108245 | PubTator, text mining | PubMed |
| Comprehensive review on gene mutations contributing to dilated cardiomyopathy. | Front Cardiovasc Med | 2023 | 38107262 | PubTator, text mining | PubMed |
| Identification of a venetoclax-resistance prognostic signature base on 6-senescence genes and its clinical significance for acute myeloid leukemia. | Front Oncol | 2023 | 38098504 | PubTator, text mining | PubMed |
| Combinational Gene Therapy toward Cancer with Nanoplatform: Strategies and Principles. | ACS Mater Au | 2023 | 38089659 | PubTator, text mining | PubMed |
| Genetic and Pharmacological Modulation of Cellular Proteostasis Leads to Partial Functional Rescue of Homocystinuria-Causing Cystathionine-Beta Synthase Variants. | Mol Cell Biol | 2023 | 38051092 | PubTator, text mining | PubMed |
| Molecular subtyping and characterization of clear cell renal cell carcinoma by tumor differentiation trajectories. | iScience | 2023 | 38034348 | PubTator, text mining | PubMed |
| Computational analysis of five neurodegenerative diseases reveals shared and specific genetic loci. | Comput Struct Biotechnol J | 2023 | 38022694 | PubTator, text mining | PubMed |
| Roles of estrogen receptor α in endometrial carcinoma (Review). | Oncol Lett | 2023 | 38020303 | PubTator, text mining | PubMed |
| Single-cell RNA-sequencing atlas reveals an FABP1-dependent immunosuppressive environment in hepatocellular carcinoma. | J Immunother Cancer | 2023 | 38007237 | PubTator, text mining | PubMed |
| Modulating Stress Proteins in Response to Therapeutic Interventions for Parkinson's Disease. | Int J Mol Sci | 2023 | 38003423 | PubTator, text mining | PubMed |
| [A case of myofibrillary myopathy due to Bcl2-Associated Athanogene 3 (BAG3) mutation complicated by peripheral neuropathy]. | Rinsho Shinkeigaku | 2023 | 37989284 | PubTator, text mining | PubMed |
| Microautophagy regulated by STK38 and GABARAPs is essential to repair lysosomes and prevent aging. | EMBO Rep | 2023 | 37987447 | PubTator, text mining | PubMed |
| Melatonin, BAG-1 and cortisol circadian interactions in tumor pathogenesis and patterned immune responses. | Explor Target Antitumor Ther | 2023 | 37970210 | PubTator, text mining | PubMed |
| Rhabdomyosarcoma: Current Therapy, Challenges, and Future Approaches to Treatment Strategies. | Cancers (Basel) | 2023 | 37958442 | PubTator, text mining | PubMed |
| Genetic testing in the management of inherited cardiac disorders: two cases of Filamin-C arrhythmogenic left ventricular cardiomyopathy. | Eur Heart J Case Rep | 2023 | 37954562 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9531/papers?page=13